Propionate and Alzheimer's Disease

Area of Science:

• Neuroscience
• Microbiology
• Metabolic Disorders

Background:

• Propionate is a vital short-chain fatty acid in human metabolism.
• Elevated propionate levels are increasingly implicated in the pathology of Alzheimer's disease (AD).
• The gut microbiome, specifically the Bacteroidetes phylum, is a primary producer of propionate.

Purpose of the Study:

• To review the current literature on the association between propionate and Alzheimer's disease (AD).
• To explore potential causes for elevated propionate levels in individuals with AD.
• To identify mechanisms linking excess propionate to AD pathogenesis and potential interventions.

Main Methods:

• Literature review of existing studies on propionate, gut microbiota, and Alzheimer's disease.
• Analysis of research linking Bacteroidetes abundance to aging and AD.
• Examination of factors such as diet, medication, and metabolism influencing propionate levels.

Main Results:

• The relative abundance of the Bacteroidetes phylum is elevated in older adults and individuals with AD.
• Diet, medication, and altered propionate metabolism are potential contributors to increased propionate.
• Mechanisms like hyperammonemia are proposed pathways through which excess propionate may induce AD.

Conclusions:

• Excessive propionate, potentially influenced by gut bacteria like Bacteroidetes, may play a role in Alzheimer's disease.
• Factors including diet, medication, and metabolic changes warrant further investigation as causes of elevated propionate.
• Understanding these mechanisms provides potential targets for novel therapeutic interventions against AD.